Global Anti-Infective Drugs Market Report 2019 provides the strategists, marketers and senior management with the critical information they need to assess the global anti-infective drugs market.
Where is the largest and fastest growing market for the anti-infective drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Anti-Infective Drugs market global report answers all these questions and many more.
The anti-infective drugs market consists of sales of anti-infective drugs and related services by entities (organizations, sole traders and partnerships) that produce anti-infective drugs to treat microbial infections. This industry includes establishments that produce antibiotics to treat bacterial infections, anti-viral drugs to treat viral infections, anti-fungal drugs to treat fungal infections, anti- helminthic drugs to kill internal parasites and antiprotozoal agents.
North America was the largest region in the global anti-infective drugs market, accounting for 44% of the market in 2018. Western Europe was the second largest region accounting for 23% of the global anti-infective drugs market. Africa was the smallest region in the global anti-infective drugs market.
Companies in this market are active with multiple strategic collaborations and agreements. Top companies in the anti-infective drug market are strategically partnering and collaborating with other companies to broaden their products and services. For instance, in May 2015, Janssen Pharmaceuticals Inc., subsidiary of Johnson & Johnson has entered into an exclusive worldwide license and collaboration arrangement with Achillion Pharmaceuticals Inc. to develop and commercialize one or more of Achillion's lead hepatitis C virus (HCV) assets which include ACH-3102, ACH-3422 and sovaprevir.
Also in December 2017, Evotec AG was in a strategic alliance with Forge Therapeutics Inc. to advance its novel Gram-negative antibiotic programme targeting 'LpxC' for the treatment of bacterial infections.
Chimerix and ContraVir Pharmaceuticals also entered into a strategic collaboration for antiviral drug candidate CMX157
Key Topics Covered:
1. Executive Summary
2. Report Structure
3. Anti-Infective Drugs Market Characteristics
3.1. Market Definition
3.2. Key Segmentations
4. Anti-Infective Drugs Market Product Analysis
4.1. Leading Products/ Services
4.2. Key Features and Differentiators
4.3. Development Products
5. Anti-Infective Drugs Market Supply Chain
5.1. Supply Chain
5.3. End Customers
6. Anti-Infective Drugs Market Customer Information
6.1. Customer Preferences
6.2. End Use Market Size and Growth
7. Anti-Infective Drugs Market Trends And Strategies
8. Anti-Infective Drugs Market Size And Growth
8.1. Market Size
8.2. Historic Market Growth, Value ($ Billion)
8.2.1. Drivers Of The Market
8.2.2. Restraints On The Market
8.3. Forecast Market Growth, Value ($ Billion)
8.3.1. Drivers Of The Market
8.3.2. Restraints On The Market
9. Anti-Infective Drugs Market Regional Analysis
9.1. Global Anti-Infective Drugs Market, 2018, By Region, Value ($ Billion)
9.2. Global Anti-Infective Drugs Market, 2014 - 2022, Historic And Forecast, By Region
9.3. Global Anti-Infective Drugs Market, Growth And Market Share Comparison, By Region
10. Anti-Infective Drugs Market Segmentation
10.1. Global Anti-Infective Drugs Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
10.1.4. Others (Anthelminthic, Antiprotozoal)
11. Anti-Infective Drugs Market Metrics
11.1. Anti-Infective Drugs Market Size, Percentage Of GDP, 2014 - 2022, Global
11.2. Per Capita Average Anti-Infective Drugs Market Expenditure, 2014 - 2022, Global
- Merck & Co
- Bristol-Myers Squibb Company
- Johnson & Johnson
For more information about this report visit https://www.researchandmarkets.com/r/snmxul